Results 231 to 240 of about 740,744 (261)

Prediction models for COVID-19 disease outcomes. [PDF]

Emerg Microbes Infect
Tang CY, Gao C, Prasai K, Li T, Dash S, McElroy JA, Hang J, Wan XF.   +7 more
europepmc   +1 more source

Association between Hematological Parameters and Severity of COVID-19 disease. [PDF]

F1000Res
Krishnan G, Karanth S, Vidyasagar S, Aggarwal A, Udupi A, Karanth S, Kaniyoor Nagri S.   +6 more
europepmc   +1 more source

Antihypertensive Drug Use and COVID-19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study. [PDF]

J Clin Hypertens (Greenwich)
Huntsman M, Marquez JL, Stoddard GJ, Wei G, Miller AJ, Agarwal JP, Jeyapalina S.   +6 more
europepmc   +1 more source

Corrigendum to "Serine protease inhibitors could be of benefit in the treatment of COVID-19 disease". [PDF]

Ther Adv Infect Dis
europepmc   +1 more source

COVID-19 and Cardiovascular Disease [PDF]

Circulation, 2020
Guideline: Diagnosis and management of cardiovascular disease during the covid-19 pandemicPublished by the European Society of Cardiology.This summary is based on the version published on 21 April 2020 (https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance)
Allan Schwartz, Justin Fried, Kevin Clerkin   +2 more
exaly   +11 more sources

Cardiovascular disease and COVID-19

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2020
Many patients with coronavirus disease 2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients.A literature search was done using PubMed and Google search ...
Manish Bansal
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

COVID-19 and liver disease

Gut, 2022
Knowledge on SARS-CoV-2 infection and its resultant COVID-19 in liver diseases has rapidly increased during the pandemic. Hereby, we review COVID-19 liver manifestations and pathophysiological aspects related to SARS-CoV-2 infection in patients without liver disease as well as the impact of COVID-19 in patients with chronic liver disease (CLD ...
Jean-François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg   +3 more
openaire   +2 more sources

COVID-19 and Cardiovascular Diseases

2021
We herein seek to expound on up-to-the-minute information regarding cardiovascular disease in the era of coronavirus disease 2019 (COVID-19) by highlighting acute myocardial injury caused by COVID-19 and probing into its pathophysiology, clinical signs, diagnostic tests, and treatment modalities.
Babak, Geraiely, Niloufar, Samiei, Parham, Sadeghipour, Azita H, Talasaz, Seyedeh Hamideh, Mortazavi, Roya, Sattarzadeh Badkoubeh   +5 more
openaire   +2 more sources

COVID-19 and Cerebrovascular Disease

Seminars in Neurology, 2023
AbstractCOVID-19 has been associated with numerous neurological complications, with acute cerebrovascular disease being one of the most devastating complications. Ischemic stroke is the most common cerebrovascular complication of COVID-19, affecting between 1 and 6% of all patients.
Christina, Catherine, Julia, Veitinger, Sherry H-Y, Chou   +2 more
openaire   +2 more sources

HIV and COVID-19 Disease

Seminars in Respiratory and Critical Care Medicine, 2023
AbstractDespite effective antiretroviral therapy (ART), HIV infected individuals throughout the world remain at significant risk of respiratory infections and non-communicable disease. Severe disease from SARS-CoV-2 is associated with a hyperinflammatory phenotype which manifests in the lungs as pneumonia and in some cases can lead to acute respiratory
openaire   +2 more sources